Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Summary of Significant Accounting Policies

Schedule of anti-dilutive common stock equivalents excluded from the calculation of diluted net loss per share

	Three and Nine Months Ended September 30,
	2023	2022
Series X Preferred Stock	5,184,591	5,242,501
Stock options	3,321,448	2,237,948
Common stock warrants	331,858	1,530,176
	8,837,897	9,010,625

Schedule of condensed consolidated statement of cash flows

The reconciliation of cash, cash equivalents and restricted cash reported within the applicable condensed consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statement of cash flows is as follows (in thousands):

	September 30,
	2023		2022
Cash and cash equivalents	$	119,806	$	45,972
Restricted cash		163		163
Total	$	119,969	$	46,135